Polycystic Ovary Syndrome Supplements Market Size, Share, Trends, Industry Analysis Report By Ingredient (Myo-Inositol-Based Supplements, Micronutrient & Omega-3 Blends), By Dosage Form, By Indication, By Sales Channel, and By Region – Market Forecast, 20

The polycystic ovary syndrome supplements market size is expected to reach USD 4.37 Billion by 2034, according to a new study by Polaris Market Research. The report “Polycystic Ovary Syndrome Supplements Market Size, Share, Trends, Industry Analysis Report By Ingredient (Myo-Inositol-Based Supplements, Micronutrient & Omega-3 Blends), By Dosage Form, By Indication, By Sales Channel, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Polycystic Ovary Syndrome (PCOS) Supplements market provides solutions for hormonal balance, menstrual cycle regulation, insulin sensitivity support, and overall reproductive health. Market growth is driven by rising awareness of PCOS management and increasing preference for safe, non-pharmacological interventions.

In addition, growing investments in nutraceutical research and development, along with the expansion of digital health platforms, are accelerating adoption of clinically supported, effective, and convenient PCOS supplement solutions.

Polycystic Ovary Syndrome Supplements Market Report Highlights

Based on Ingredient, the myo-inositol-based supplements segment dominated in 2024, driven by strong clinical evidence supporting improved insulin sensitivity and hormonal balance.

In terms of Dosage Form, capsules & tablets held the largest share, owing to their convenience, accurate dosage delivery, and wide consumer acceptance.

Based on Indication, the menstrual cycle support segment led the market, reflecting rising demand for safe, non-pharmacological solutions to regulate irregular cycles.

In terms of Sales Channel, online stores dominated, boosted by home delivery convenience, subscription models, and growing trust in digital health platforms.

North America led the market in 2024, driven by increasing awareness of nutraceuticals and dietary supplements for managing hormonal imbalances.

Asia Pacific is expected to witness strong growth, fueled by rising interest in natural and herbal remedies for managing PCOS symptoms.

Key players in the global market include Allara Health, Inc., Amway Corporation, Fertility Family Ltd., Garden of Life, LLC, Girl Vitamins, LLC, Himalaya Wellness Company, Herbalife Nutrition Ltd., MyOva Ltd., New Leaf Products Ltd., NOW Health Group, Inc. (NOW Foods), SOVA Supplements Ltd., The S’moo Co., Theralogix LLC, Thorne HealthTech, Inc., and Zazzee Naturals LLC.

Request a free sample copy or read the full market insights : polycystic ovary syndrome supplements market report

Polaris Market Research has segmented the market report based on ingredient, dosage form, indication, sales channel, and region:

By Ingredient Outlook (Revenue, USD Billion, 2020–2034)

Myo‑inositol-based supplements

Micronutrient & Omega-3

Herbal Supplements

Others

By Dosage Form Outlook (Revenue, USD Billion, 2020–2034)

Capsules & tablets

Powders

Gummies

Liquids

By Indication Outlook (Revenue, USD Billion, 2020–2034)

Menstrual Cycle Support

Hormonal Regulation

Fertility Improvement

Acne and Skin Health

Others

By Sales Channel Outlook (Revenue, USD Billion, 2020–2034)

Hypermarket & Supermarket

Pharmacy & Drug stores

Online Stores

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America Show more